Cambridge Investment Research Advisors, Inc. Prothena Corp Public LTD CO Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,164 shares of PRTA stock, worth $98,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,164Holding current value
$98,590% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PRTA
# of Institutions
199Shares Held
39.4MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$112 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$37.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$35.8 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$21.7 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$18.1 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $455M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...